The Bull Market Report Publishes In-Depth Report on Stem Cell Companies
March 07 2006 - 7:00AM
PR Newswire (US)
PRINCETON, N.J., March 7 /PRNewswire/ -- The Bull Market Report
(http://www.bullmarket.com/), an online investment newsletter
focused on long- term growth and income-generating stocks,
announced that it has published an in-depth report on biotech
companies focused on stem cell research, including Geron
(NASDAQ:GERN), StemCells (NASDAQ:STEM), Aastrom Biosciences
(NASDAQ:ASTM), and ViaCell (NASDAQ:VIAC). All paid and trial
subscribers to The Bull Market Report can now receive immediate
access to the newsletter's exclusive daily reports. As a
subscriber, you'll also gain access to our latest investment moves.
Start your 14-day free trial today:
https://www.bullmarket.com/subscribe/index.php?refer=BMR97 In its
report, The Bull Market Report wrote: "Valuing these companies is
quite difficult, as profitably can be as much as a decade away, if
it can ever be obtained at all. Their potential as an investment,
however, cannot be ignored. For the companies involved in embryonic
stem cell research, government funding and ethical issues will
remain a hindrance to research and growth. Additionally, the stem
lines currently available to receive government funding are
dwindling." In its coverage, The Bull Market Report looked at the
following topics: -- Why is it important to differentiate companies
doing stem cell research with adult and umbilical cord stem cells
versus those using embryonic stem cells? -- What catalysts will
drive these stocks in the near to medium term? -- Which companies
look the most appealing as potential long-term investments? -- What
is the best strategy to employ for long-term investors interested
in investing in this niche of the biotech sector? About The Bull
Market Report: Launched in 1997, The Bull Market Report has a
strong track record of creating wealth for its subscribers by
providing sound, long-term investing advice. The Bull Market
Report's Recommended List includes over 50 companies across all
major industries, including Financials, Healthcare, Energy,
Technology, and Retail, among others. The Bull Market Report is one
of the oldest continuously published investment newsletters online.
NOTE: This release was published by Indie Research Advisors, LLC
(CRD #131926), a registered investment advisor with the NASD and
State of NJ. Past performance does not guarantee future results.
Investors should always research companies and securities before
making any investments. Nothing herein should be construed as an
offer or solicitation to buy or sell any security. CONTACT: Marcie
Martin, +1-888-278-5515 DATASOURCE: Indie Research Advisors, LLC
CONTACT: Marcie Martin, Indie Research Advisors, LLC,
+1-888-278-5515 Web site: http://www.bullmarket.com/
Copyright
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Jul 2023 to Jul 2024